These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 492291)

  • 1. Hypercalcemia during long-term treatment with 1,25-dihydroxyvitamin D3 in hypoparathyroidism.
    Bell NH; Epstein S; Stern PH
    N Engl J Med; 1979 Nov; 301(21):1183-4. PubMed ID: 492291
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypercalcemia and increases in serum hormone value during prolonged administration of 1alpha,25-dihydroxyvitamin D.
    Bell NH; Stern PH
    N Engl J Med; 1978 Jun; 298(22):1241-3. PubMed ID: 651964
    [No Abstract]   [Full Text] [Related]  

  • 3. [Severe hypercalcemia during treatment of Fahr's syndrome with alfacalcidol].
    Turpin G; Poirier M; Scherrer H; Metzger J; De Gennes JL
    Presse Med; 1986 Jan; 15(1):36. PubMed ID: 2935853
    [No Abstract]   [Full Text] [Related]  

  • 4. 1,25-dihydroxy-vitamin D3: a new treatment for hypoparathyroidism.
    Glatthaar C; Smith R; Espiner EA; Donald RA; Hinton D
    N Z Med J; 1980 Oct; 92(669):267-71. PubMed ID: 6934421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1alpha-hydroxyvitamin D3 in the long-term management of hypoparathyroidism and pseudohypoparathyroidism.
    Lewin IG; Papapoulos SE; O'Riordan JL
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():203s-207s. PubMed ID: 606417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercalcaemia in alphacalcidol therapy.
    Paterson CR
    Postgrad Med J; 1981 Jul; 57(669):431-2. PubMed ID: 7312738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
    Kooh SW; Fraser D; DeLuca HF; Holick MF; Belsey RE; Clark MB; Murray TM
    N Engl J Med; 1975 Oct; 293(17):840-4. PubMed ID: 170516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,25-Dihydroxycholecalciferol: its use in the long-term management of idiopathic hypoparathyroidism in children.
    Rosen JF; Fleischman AR; Finberg L; Eisman J; DeLuca HF
    J Clin Endocrinol Metab; 1977 Sep; 45(3):457-68. PubMed ID: 903398
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypoparathyroidism--a long-term follow-up experience with 1 alpha-vitamin D3 therapy.
    Halabe A; Arie R; Mimran D; Samuel R; Liberman UA
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):303-7. PubMed ID: 8187292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcifediol (25-hydroxyvitamin D3) in the treatment of uremic bone disease.
    Teitelbaum SL
    Ann Intern Med; 1981 Mar; 94(3):404-5. PubMed ID: 6894359
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe hypercalcemia in a patient treated for hypoparathyroidism with calcitriol.
    De Sanctis V; Fiscina B; Ciccone S
    Pediatr Endocrinol Rev; 2010 Jun; 7(4):363-5. PubMed ID: 20679997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs in current use: calcitriol.
    Aust Nurses J; 1980 Feb; 9(7):27-8. PubMed ID: 6900485
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypoparathyroidism and pregnancy. Treatment with calcitriol.
    Sadeghi-Nejad A; Wolfsdorf JI; Senior B
    JAMA; 1980 Jan; 243(3):254-5. PubMed ID: 7350374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Danazol-induced hypercalcaemia in alphacalcidol-treated hypoparathyroidism.
    Hepburn NC; Abdul-Aziz LA; Whiteoak R
    Postgrad Med J; 1989 Nov; 65(769):849-50. PubMed ID: 2616424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is calcitriol [1,25(OH)2D3] harmful to renal function?
    Massry SG; Goldstein DA
    JAMA; 1979 Oct; 242(17):1875-6. PubMed ID: 480619
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypercalcemia in children with disorders of calcium and phosphate metabolism during long-term treatment with 1,25-dihydroxyvitamin-D3.
    Chan JC; Young RB; Alon U; Mamunes P
    Pediatrics; 1983 Aug; 72(2):225-33. PubMed ID: 6688127
    [No Abstract]   [Full Text] [Related]  

  • 17. Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its 1alpha-hydroxylated derivatives.
    Kanis JA; Russell RG
    Br Med J; 1977 Jan; 1(6053):78-81. PubMed ID: 832019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: Some long-term effects of 1,25 dihydroxycholecalciferol (1,25(OH)2D3) in man.
    Henderson RG; Ledingham JG; Oliver DO; Small DG; Russell RG; Smith R; Walton RJ; Norman AW
    Clin Sci Mol Med; 1974 Feb; 46(2):10P. PubMed ID: 4817248
    [No Abstract]   [Full Text] [Related]  

  • 19. Ultrastructural evaluation of parathyroid glands and thyroid C cells of cattle fed Solanum malacoxylon.
    Collins WT; Capen CC; Döbereiner J; Tokarnia CH
    Am J Pathol; 1977 Jun; 87(3):603-14. PubMed ID: 869016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physiologic role, biosynthesis and use of 1,25-dihydroxyvitamin D3 (review)].
    Bauman VK
    Prikl Biokhim Mikrobiol; 1976; 12(6):805-18. PubMed ID: 799296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.